Zobrazeno 1 - 10
of 2 014
pro vyhledávání: '"Banfield, C."'
Autor:
Wojciechowski J; Pfizer Inc., Groton, Connecticut, USA., Mukherjee A; Pfizer Inc., Groton, Connecticut, USA., Banfield C; Pfizer Inc., Cambridge, Massachusetts, USA., Nicholas T; Pfizer Inc., Groton, Connecticut, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Sep; Vol. 116 (3), pp. 724-735. Date of Electronic Publication: 2024 Apr 16.
Autor:
Qiu R; Pfizer Inc, Cambridge, Massachusetts, USA., Sharma R; Pfizer Inc, Groton, Connecticut, USA., Wei H; Pfizer Inc, Shanghai, China., Kirkovsky L; Pfizer Inc, La Jolla, California, USA., Zhou Y; Pfizer Inc, Collegeville, Pennsylvania, USA., Martin DDA; Pfizer Inc, Cambridge, Massachusetts, USA., Banfield C; Pfizer Inc, Cambridge, Massachusetts, USA., Dowty ME; Pfizer Inc, Cambridge, Massachusetts, USA.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2023 Oct; Vol. 89 (10), pp. 3056-3066. Date of Electronic Publication: 2023 Jun 20.
Autor:
Bauman JN; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.) jonathan.bauman@pfizer.com., Doran AC; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Gualtieri GM; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Hee B; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Strelevitz T; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Cerny MA; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Banfield C; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Plotka A; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Wang X; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Purohit VS; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.)., Dowty ME; Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc., Cambridge, Massachusetts (M.E.D.) andGroton, Connecticut (J.N.B., A.C.D., G.M.G., B.H., T.S., M.A.C.); Clinical Pharmacology, Pfizer, Inc., Groton, Connecticut (C.B., X.W., V.S.P.); Biostatistics, Pfizer, Inc., Collegeville, Pennsylvania (A.P.).
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Sep 16; Vol. 52 (10), pp. 1124-1136. Date of Electronic Publication: 2024 Sep 16.
Autor:
Hassan-Zahraee M; Pfizer Inc, Cambridge, MA, USA., Ye Z; Pfizer Inc, Cambridge, MA, USA., Xi L; Pfizer Inc, Cambridge, MA, USA., Dushin E; Pfizer Inc, Cambridge, MA, USA., Lee J; Pfizer Inc, Cambridge, MA, USA., Romatowski J; Provincial Complex Hospital, Gastroenterology, Bialystok, Poland., Leszczyszyn J; Melita Medical, Gastroenterology, Wroclaw, Poland., Danese S; IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy., Sandborn WJ; University of California San Diego, La Jolla, CA, USA., Banfield C; Pfizer Inc, Cambridge, MA, USA., Gale JD; Pfizer Inc, Cambridge, MA, USA., Peeva E; Pfizer Inc, Cambridge, MA, USA., Longman RS; Weill Cornell Medicine, Division of Gastroenterology and Hepatology, New York, NY, USA., Hyde CL; Pfizer Inc, Cambridge, MA, USA., Hung KE; Pfizer Inc, Cambridge, MA, USA.
Publikováno v:
Journal of Crohn's & colitis [J Crohns Colitis] 2024 Sep 03; Vol. 18 (9), pp. 1361-1370.
Autor:
Tsamandouras N; Clinical Pharmacology, Early Clinical Development, Worldwide Research, Development and Medical, Pfizer, Cambridge, MA, USA. nikolaos.tsamandouras@pfizer.com., Qiu R; Clinical Pharmacology, Early Clinical Development, Worldwide Research, Development and Medical, Pfizer, Cambridge, MA, USA., Hughes JH; Clinical Pharmacology, Global Product Development, Pfizer, Groton, CT, USA., Sweeney K; Clinical Pharmacology, Global Product Development, Pfizer, Groton, CT, USA., Prybylski JP; Clinical Pharmacology, Global Product Development, Pfizer, Groton, CT, USA., Banfield C; Clinical Pharmacology, Early Clinical Development, Worldwide Research, Development and Medical, Pfizer, Cambridge, MA, USA., Nicholas T; Clinical Pharmacology, Global Product Development, Pfizer, Groton, CT, USA.
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2024 Jun; Vol. 51 (3), pp. 265-277. Date of Electronic Publication: 2024 Mar 03.
Autor:
Peeva E; Pfizer Inc., 1 Portland St, Cambridge, MA 02139, USA. Electronic address: Elena.Peeva@pfizer.com., Banerjee A; Pfizer Inc., 1 Portland St, Cambridge, MA 02139, USA., Banfield C; Pfizer Inc., 1 Portland St, Cambridge, MA 02139, USA., Soma K; Pfizer Inc., 445 Eastern Point Road, Groton, CT 06340, USA., Christensen J; Pfizer Inc., 1 Portland St, Cambridge, MA 02139, USA., Menon S; Pfizer Inc., 1 Portland St, Cambridge, MA 02139, USA., Vincent MS; Pfizer Inc., 1 Portland St, Cambridge, MA 02139, USA., Dolsten M; Pfizer Inc., 66 Hudson Blvd East, New York City, NY 10001, USA.
Publikováno v:
Drug discovery today [Drug Discov Today] 2024 May; Vol. 29 (5), pp. 103948. Date of Electronic Publication: 2024 Mar 08.
Autor:
Maleki F; Clinical Pharmacology and Bioanalytics, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, Massachusetts, USA., Clark E; Department of Mathematics, University of Utah, Salt Lake City, Utah, USA., Banfield C; Clinical Pharmacology and Bioanalytics, Worldwide Research, Development and Medical, Pfizer Inc., Cambridge, Massachusetts, USA., Byon W; Amador Bioscience, Ann Arbor, Michigan, USA., Nicholas T; Clinical Pharmacology and Bioanalytics, Worldwide Research, Development and Medical, Pfizer Inc, Groton, Connecticut, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Apr; Vol. 13 (4), pp. 551-562. Date of Electronic Publication: 2024 Feb 08.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kimball AB; Harvard Medical School and Beth Israel Deaconess Medical Center, Boston., Peeva E; Pfizer Inc, Collegeville, PA., Forman S; ForCare Medical Center, Tampa, FL., Moiin A; Revival Research Institute, LLC, Southfield, MI., Khattri S; Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York., Porter ML; Harvard Medical School and Beth Israel Deaconess Medical Center, Boston., Mangold AR; Department of Dermatology, Mayo Clinic Arizona, Scottsdale, AZ., Ghosh P; Pfizer, Inc., Cambridge, MA., Banfield C; Pfizer, Inc., Cambridge, MA., Oemar B; Pfizer, Inc., Cambridge, MA.
Publikováno v:
NEJM evidence [NEJM Evid] 2024 Mar; Vol. 3 (3), pp. EVIDoa2300155. Date of Electronic Publication: 2024 Feb 09.
Autor:
Bodenlenz M; HEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria., Yeoh T; Pfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA., Berstein G; Pfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA., Mathew S; Pfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA. Shibin.Mathew@pfizer.com., Shah J; Pfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA., Banfield C; Pfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA., Hollingshead B; Pfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA., Steyn SJ; Pfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA., Osgood SM; Pfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA., Beaumont K; Pfizer Research Technology Center, 1 Portland St, Cambridge, MA, 02139, USA., Kainz S; HEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria., Holeček C; HEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria., Trausinger G; HEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria., Raml R; HEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria., Birngruber T; HEALTH - Institute for Biomedical Research and Technologies, Joanneum Research Forschungsgesellschaft M.B.H, Neue Stiftingtalstrasse 2, 8010, Graz, Austria. healthca@joanneum.at.
Publikováno v:
Pharmaceutical research [Pharm Res] 2024 Feb; Vol. 41 (2), pp. 223-234. Date of Electronic Publication: 2023 Dec 29.